1
Arnaiz Damian O, Chou You Ling, Kochanny Monica J, Lee Wheeseong, Lu Shou Fu, Mengel Anne, Phillips Gary, Wei Guo Ping, Yu Hongyi: Piperidine derivatives as antagonists of the cc chemokine receptor ccr1 and their use as anti-inflammatory agents. Schering Aktiengesellschaft, Arnaiz Damian O, Chou You Ling, Kochanny Monica J, Lee Wheeseong, Lu Shou Fu, Mengel Anne, Phillips Gary, Wei Guo Ping, Yu Hongyi, June 29, 2006: WO/2006/066948 (32 worldwide citation)

Piperidine derivatives of the following formulae (I) and (II) and their pharmaceutically acceptable salts, which are functional antagonists of the CC chemokine receptor CCR1 and are thus useful as anti inflammatory agents, a pharmaceutical compositions containing said piperidine derivatives or their ...


2
Arnaiz Damian O, Baldwin John J, Davey David D, Devlin James J, Dolle Roland Ellwood Iii, Erickson Shawn David, Mcmillan Kirk, Morrissey Michael M, Ohlmeyer Hichael H J, Pan Gonghua, Paradkar Vidyadhar Madhav, Parkinson John, Phillips Gary B, Ye bin, Zhao Zuchun: N-heterocyclic derivatives as nos inhibitors. Berlex Lab, Pharmacopeia, January 5, 2000: EP0968206-A1 (1 worldwide citation)

N-Heterocyclic derivatives of formula (I) are described herein, as well as other N-Heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors of nitric oxide synthase and processes for synthesizing thes ...


3
Arnaiz Damian O, Griedel Brian D, Sakata Stephen T, Shaw Kenneth J, Zhao Zuchan: Naphthyl-substituted benzimidazole derivatives as anticoagulants. Berlex Laboratories, June 19, 1997: WO/1997/021437 (1 worldwide citation)

Novel naphthyl-substituted benzimidazole compounds and their pharmaceutically acceptable salts are described herein. This invention is also directed to an anticoagulant composition comprising a naphthyl-substituted benzimidazole compound described herein. The novel compound or its composition has in ...


4

5
Arnaiz Damian O, Baldwin John J, Davey David D, Devlin James J, Dolle Roland Elwood Iii, Erickson Shawn David, Mcmillan Kirk, Morrissey Michael M, Ohlmeyer Michael H J, Pan Gonghua, Paradkar Vidyadhar Madhav, Parkinson John, Phillips Gary B, Ye bin, Zhao Zuchun: N-heterocyclic derivatives as nos inhibitors. Berlex, Pharmacopeia, February 21, 2007: EP1754703-A2

N-Heterocyclic derivatives of formula (I) are described herein, as well as other N-Heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors of nitric oxide synthase and processes for synthesizing thes ...


6
Baldwin John J, Arnaiz Damian O, Davey David D, Devlin James J, Dolle Roland Ellwood Iii, Erickson Shawn David, Mcmillian Kirk, Morrissey Michael M, Ohlmeyer Hichael H J, Pan Gonghua, Paradkar Vidyadhar Madhav, Phillips Gary B, Parkinson John, Ye bin, Zhao Zuchun: N-heterocyclic derivatives as nos inhibitors. Berlex Lab, Pharmacopeia, January 12, 2000: GB2338957-A

N-Heterocyclic derivatives of formula (I) are described herein, as well as other N-Heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors of nitric oxide synthase and processes for synthesizing thes ...


7

8
Pan Gonghua, Mcmillan Kirk, Davey David D, Ohlmeyer Michael H J, Dolle Roland Ellwood Iii, Erickson Shawn David, Zhao Zuchun, Devlin James J, Paradkar Vidyadhar Madhav, Ye bin, Morrissey Michael M, Baldwin John J, Parkinson John, Phillips Gary B, Arnaiz Damian O: Derives n-heterocycliques utiles en tant quinhibiteurs de la no synthetase, N-heterocyclic derivatives as nos inhibitors. Berlex Laboratories, Pharmacopeia, Berlex Laboratories, Pharmacopeia, MARKS & CLERK, August 27, 1998: CA2281545

N-Heterocyclic derivatives of formula (I) are described herein, as well as other N-Heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors of nitric oxide synthase and processes for synthesizing thes ...


9
Kosemund Dirk, Schulza Volker, Eis Knut, Wortmann Lars, Prien Olaf, Siemeister Gehard, Hess Stumpp Holger, Eberspaecher Uwe, Arnaiz Damian O: Thiazolidinones for use as inhibitors of polo-like kinase (plk). Bayer Schering Pharma, zhangxiao wei, April 2, 2008: CN200680011119

The invention relates to the thiazolidinones of general formula (I), to the production and use thereof as inhibitors of Polo-like kinase (Plk) for use in the treatment of various diseases.


10
ARNAIZ DAMIAN O, BALDWIN JOHN J, DAVEY DAVID D, DEVLIN JAMES J, DOLLE ROLAND ELLWOOD III, ERICKSON SHAWN DAVID, MCMILLAN KIRK, MORRISSEY MICHAEL M, OHLMEYER MICHAEL H J, PAN GONGHUA, PARADKAR VIDYADHAR MADHAV, PARKINSON JOHN, PHILLIPS GARY B, YE BIN, ZHAO ZUCHUN: DERIVES N-HETEROCYCLIQUES SOUS FORME DINHIBITEURS OXYDE NITRIQUE SYNTHASE, N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS. BERLEX LABORATORIES, PHARMACOPEIA, BERLEX LABORATORIES, PHARMACOPEIA, MARKS & CLERK, October 27, 2009: CA2376355

N-Heterocyclic derivatives of formula (Ya) are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors of nitric oxide synthase and processes for synthesizing the ...